Professor Angela Morgan
Professor Angela Morgan leads the NHMRC CRE in Speech and Language. She is an NHMRC Practitioner Fellow and leads the Speech and Language group at the Murdoch Children's Research Institute. She is also Professor of Speech Pathology at the University of Melbourne. Angela has over 20 years of clinical-research experience across Australia and the United Kingdom (University College London Institute of Child Health and Great Ormond Street Hospital).
Her current research program focuses on: (i) identification of new gene pathways leading to child speech and language disorders, (ii) conducting genotype- speech phenotype studies for rare genetic syndromes leading to more targeted therapies, and (iii) elucidating the neurobiology of speech and language disorders using quantitative brain imaging techniques. In recent years, Angela and team have identified a number of novel genes not previously associated with severe speech disorder. Her team have also characterised speech and language abilities in children with a number of genetic conditions, including: FOXP2-related speech and language disorders, Kabuki syndrome, Floating Harbor Syndrome, 16p11.2 deletion, Koolen de Vries Syndrome, GRIN2A-related speech disorder, SETBP1-related speech disorder, Dravet Syndrome and Klinefelter Syndrome. Together with Associate Professor Frederique Liegeois at UCL, Angela has been studying novel brain pathways associated with severe speech and language disorder. Increasingly, Angela is a consultant on speech outcomes for pharmacological trials in children with rare genetic conditions. Angela also holds an NHMRC development grant to develop a digital speech outcome measure.Discover more about Professor Angela Morgan